SGP
SpyGlass Pharma, Inc.
NASDAQ: SGP · HEALTHCARE · BIOTECHNOLOGY
$22.94
+3.66% today
Updated 2026-04-30
Market cap
$786.19M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.25
Dividend yield
—
52W range
$20 – $32
Volume
0.1M
SpyGlass Pharma, Inc. (SGP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | $-12.28M | $-22.03M | $-32.70M |
| Capital expenditures | $216542.00 | $1.99M | $789000.00 |
| Depreciation | — | — | — |
| Stock-based comp | $874196.00 | $1.49M | $2.79M |
| Free cash flow | $-12.49M | $-24.02M | $-33.49M |
| Investing cash flow | — | — | — |
| Financing cash flow | — | — | — |
| Dividends paid | — | — | — |
| Share repurchases | — | — | — |
| Debt repayment | — | — | — |
| Net change in cash | — | — | — |